Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-06-21

Clinical Trial Update: Harnessing Chronomodulation to Enhance Osteogenesis [Phase 4]

View source ↗

Summary

Phase 4 trial exploring chronomodulation to enhance osteogenesis for tooth loss has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Iowa | Conditions: Tooth Loss | Phase 4 | Status: WITHDRAWN